Physician Assistant in Wall, NJ Accepting Medicare
3 Physician Assistant nurses found. Showing 1 - 3
 Iris Dubetsky, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 2510 Belmar Blvd Ste I-1, Wall, NJ 07719 Phone: 609-495-8644 Fax: 908-520-4216 |
Mrs. Isabel Agabs, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1985 Highway 34 South, Unit A8, Wall, NJ 07719 Phone: 732-943-1811 |
Kim H Morales, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: Suite 122 3350 Hwy 138 West, Wall, NJ 07719 Phone: 732-280-1200 Fax: 732-280-1207 |
News Archive
Third party reexamination of Phase III study of Ereska meets primary endpoint
Javelin Pharmaceuticals, Inc. today announced that a reexamination conducted by a third party of pain score measurements from its Phase III study of Ereska™ (intranasal ketamine) showed that top line results for its primary endpoint were statistically significant. Previously, Javelin had reported that the top line results for its primary endpoint were not statistically significant.
Nearly identical brain activity is evoked from processing written or spoken words
The brain activity evoked from processing written or heard semantic information is almost identical, according to research in adults published in JNeurosci. These findings add to the understanding of how the brain processes written and oral language.
Ibuprofen may be used effectively for altitude sickness: Study
Altitude sickness manifests by symptoms including a headache, fatigue, dizziness and sometimes nausea and vomiting. In addition, patients most likely also feel like they are working harder to breathe, like they are constantly trying to catch their breath. It normally takes days to weeks to fully acclimate to a higher altitude. It affects between 25 percent and 40 percent of the population and can be debilitating.
Leukemic cells find safe haven in bone marrow
The cancer drug asparaginase fails to help cure some children with acute lymphoblastic leukemia (ALL) because molecules released by certain cells in the bone marrow counteract the effect of that drug, according to St. Jude investigators.
Relevare Pharmaceuticals to present CNSB015 Phase IIa results at international neuropathic pain congress
Relevare Pharmaceuticals Ltd. will present its recent Phase IIa proof-of-concept clinical trial data and extension study results for CNSB015 (flupirtine), its lead repositioned compound, at the Third International Congress on Neuropathic Pain on May 27 –30 in Athens, Greece.
› Verified 1 days ago